During the past decade, Hudson Valley Oncology Associates conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 16 clinical trials were completed, i.e. on average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 8 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hudson Valley Oncology Associates" #1 sponsor was "Radiation Therapy Oncology Group" with 6 trials, followed by "National Cancer Institute (NCI)" with 5 trials sponsored, "NSABP Foundation Inc" with 2 trials sponsored, "Amgen" with 1 trials sponsored and "GlycoMimetics Incorporated" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hudson Valley Oncology Associates" #1 collaborator was "National Cancer Institute (NCI)" with 9 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator and "North Central Cancer Treatment Group" with 3 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Hudson Valley Oncology Associates" are "Breast Cancer" (5 trials), "Prostate Cancer" (3 trials), "Acute Myeloid Leukemia" (2 trials), "Breast Adenocarcinoma" (2 trials) and "Multiple Myeloma" (2 trials). Many other conditions were trialed in "Hudson Valley Oncology Associates" in a lesser frequency.

Most popular intervention types in "Hudson Valley Oncology Associates" are "Drug" (14 trials), "Radiation" (10 trials), "Other" (5 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (4 trials), "Bevacizumab" (3 trials), "Placebo" (3 trials), "Quality-of-Life Assessment" (3 trials) and "Letrozole" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hudson Valley Oncology Associates" are 11 trials for "All" genders, 5 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Hudson Valley Oncology Associates". undefined are not yet recruiting, undefined are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Hudson Valley Oncology Associates, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hudson Valley Oncology Associates, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Hudson Valley Oncology Associates has several departments that took part in Clinical trials: "Hudson Valley Hematology and Oncology Associates" - 2 trials